COVID-19 R&D Implementation scheme (SMART)

Funded by European Regional Development fund. Funded as part of the European Union’s response to the COVID-19 pandemic.

The activity is funded under Measure 01.2.2-LMT-K-718 ‘Targeted Research in Smart Specialisation Areas’ (Funding instrument - European Regional Development Fund). Measure implementation is managed by the Ministry of Education, Science and Sport of the Republic of Lithuania and the Research Council of Lithuania.

The purpose of the measure is to implement research projects intended to develop results compliant with R&D relevant for economic sectors and that could subsequently be commercialised.

The puspose of activity is to develop applied knowledge contributing to reducing/resolving the problems caused by the COVID-19 virus and increasing public resilience to similar potential crises. Projects, funded according to this activity, are intended to investigate the COVID-19 and/or the economic, social and cultural consequences of this virus

The budget of the call € 10 000 000.

Maximum eligible costs per project € 300 000.

Project activities must be completed by 1st of September, 2023 at the latest.

Eligible Applicants:

• Research and studies institutions, Universities included in the Open Information, Counselling and Guidance System AIKOS
• University Hospitals.

Eligible Partners:

• Legal entities operating in research (that have been engaged in R&D activities in the course of previous 12 months prior to the last day for the submission of the application).

Project implementation costs:

• Personnel costs of PI and research group (unit costs).
• Travel allowance (EU countries only) (unit costs).

Indirect and other costs according to the flat rate:

• Research implementation costs.
• Indirect costs (project administration and related costs).

Project selection criteria:

• The project complies with the provisions of the Smart Specialization Program and the implementation topic of at least one priority.
• The project contributes to reducing / solving the problems caused by the COVID-19 virus and increasing public resilience to similar potential crises.

The project must aim for at least one of the specified results:

• Developed and tested innovative, research and/or technology based and/or user-friendly product and/or process (applicable to the Social Sciences and Humanities (HS) and the Natural Sciences, Technology, Medicine and Health and Agricultural Sciences (NTMA) projects);
• The product and/or process of the R&D activity, the actual operation of which has been verified by simulating the real environment (conditions). Stakeholders of the product and/or process must confirm that the developed product and/or process is suitable for obtaining the intended results (applicable to NTMA and HS projects);
• Open source digital resources (applicable to NTMA and HS projects);
• Scientific article in a journal with a citation index JIF CA JCR (Clarivate Analytics Journal Citation Reports) (applicable to NTMA projects);
• Scientific article in a journal with a citation index JIF CA JCR or SNIP SCOPUS (SNIP – Source-Normalized Impact per Paper) (applicable to HS projects)

Related documents:

• Guidelines for applicants
• Application form
• Assessment table (HS projects)
• Assessment table (NTMA projects)
• Score assigned to research and studies institutions in research area for projects of international research programmes and R&D orders from economic entities

Contact: Jolanta Petrauskaitė +370 604 53 567, jolanta.petrauskaitė@lmt.lt